Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

Jessica Slostad, Patrick Hoversten, Candace L. Haddox, Kamila Cisak, Jonas Paludo, Ayalew Tefferi

Research output: Contribution to journalArticle

20 Scopus citations
Original languageEnglish (US)
JournalAmerican Journal of Hematology
DOIs
StateAccepted/In press - Jan 1 2017

ASJC Scopus subject areas

  • Hematology

Cite this